Egetis Therapeutics AB (publ) (STO:EGTX)

Egetis Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,929	2,515	1,633	1,524	1,108	1,233
Market Cap Growth	-26.75%	54.03%	7.15%	37.56%	-10.17%	15.17%
Enterprise Value	1,763	2,497	1,550	1,335	939	1,074
Last Close Price	5.37	7.00	5.58	7.10	6.16	6.85
Forward PE	7.78	-	-	-	-	4.89
PS Ratio	41.31	54.55	28.34	67.42	29.00	30.33
PB Ratio	4.45	5.10	2.99	3.01	2.10	1.96
P/TBV Ratio	4.48	5.14	3.02	3.04	2.13	1.98
EV/Sales Ratio	37.75	54.16	26.91	59.07	24.58	26.41
Debt / Equity Ratio	0.25	0.24	0.21	0.01	0.01	0.01
Asset Turnover	0.07	0.06	0.09	0.04	0.06	0.08
Inventory Turnover	33.82	13.65	16.92	219.39	50.34	-
Quick Ratio	1.51	1.83	3.27	2.80	3.85	4.21
Current Ratio	1.53	1.86	3.33	2.98	3.90	4.28
Return on Equity (ROE)	-73.19%	-66.17%	-62.16%	-37.51%	-18.05%	-40.66%
Return on Assets (ROA)	-27.92%	-25.91%	-29.45%	-21.78%	-10.22%	-22.42%
Return on Capital (ROIC)	-35.14%	-31.71%	-33.33%	-23.68%	-11.27%	-25.14%
Earnings Yield	-17.18%	-13.66%	-20.02%	-12.72%	-9.44%	-14.44%
FCF Yield	-12.39%	-9.06%	-17.05%	-11.39%	-11.76%	-10.92%
Buyback Yield / Dilution	-19.69%	-19.57%	-33.86%	-7.97%	-166.96%	-30.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.